HealthDay – SUNDAY, March 30 (HealthDay News) — A divided cardiology community is trying once again to make sense of a trial showing that a drug can lower levels of “bad” LDL thin and yet give no apparent benefit to people at high risk of heart attack and other cardiovascular problems. More: – Continued here

More: continued here